These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6796706)

  • 1. Nationwide ALT testing to prevent non-A, non-B hepatitis still on hold.
    Cowart VS
    JAMA; 1981 Dec; 246(24):2791-2. PubMed ID: 6796706
    [No Abstract]   [Full Text] [Related]  

  • 2. Screening of blood donors.
    Carlson RE; Hering PJ
    JAMA; 1981 Sep; 246(11):1195. PubMed ID: 6790735
    [No Abstract]   [Full Text] [Related]  

  • 3. Non-A, non-B hepatitis surrogate testing of blood donations.
    Lancet; 1987 Jun; 1(8546):1366-7. PubMed ID: 2884466
    [No Abstract]   [Full Text] [Related]  

  • 4. Should donor blood be screened for elevated alanine aminotransferase levels? A cost-effectiveness analysis.
    Silverstein MD; Mulley AG; Dienstag JL
    JAMA; 1984 Nov 23-30; 252(20):2839-45. PubMed ID: 6436522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-transfusion non-A, non-B hepatitis: significance of raised ALT and anti-HBc in blood donors.
    Biswas R
    Vox Sang; 1989; 56(1):63. PubMed ID: 2492703
    [No Abstract]   [Full Text] [Related]  

  • 6. Reducing hepatitis by testing blood for alanine aminotransferase.
    Kahn RA
    N Engl J Med; 1983 Apr; 308(14):844-5. PubMed ID: 6403860
    [No Abstract]   [Full Text] [Related]  

  • 7. Surrogate testing for non-A, non-B hepatitis.
    Anderson CC; Contreras M; Barbara JA; Mijovic V
    Lancet; 1987 Apr; 1(8538):912. PubMed ID: 2882303
    [No Abstract]   [Full Text] [Related]  

  • 8. [Screening of blood donors for the prevention of non-A, non-B hepatitis].
    Seidl S
    Dtsch Med Wochenschr; 1983 Jan; 108(4):123-4. PubMed ID: 6402351
    [No Abstract]   [Full Text] [Related]  

  • 9. [Significance of alanine aminotransferase and reduction of post-transfusion non-A, non-B hepatitis].
    Hoang B; Simonneau M; Le Xuan P; Guichoux P; Terrier E; Ruffie J
    Rev Fr Transfus Hemobiol; 1989 Apr; 32(2):93-106. PubMed ID: 2502996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alanine aminotransferase and posttransfusion hepatitis.
    Lacher DA
    JAMA; 1987 Feb; 257(8):1048. PubMed ID: 3100827
    [No Abstract]   [Full Text] [Related]  

  • 11. [ALT determination in blood donors].
    Franco E; Sedeño M
    Sangre (Barc); 1994 Apr; 39(2):153. PubMed ID: 8059298
    [No Abstract]   [Full Text] [Related]  

  • 12. Screening of donor blood for alanine aminotransferase.
    Fiedler H
    JAMA; 1985 Dec; 254(24):3422. PubMed ID: 3934400
    [No Abstract]   [Full Text] [Related]  

  • 13. Measurement of alanine aminotransferase (ALT) levels in Zimbabwean donor serum--a possible indicator of non-A, non-B hepatitis.
    Emmanuel JC; Bassett MT; Smith HJ; Paterson LE
    Cent Afr J Med; 1989 Aug; 35(8):469-70. PubMed ID: 2509075
    [No Abstract]   [Full Text] [Related]  

  • 14. [Prevention of non-A non-B hepatitis in Guadeloupe].
    Fest T; Gordien E; Neubauer J; Citadelle E; Agis F
    Rev Fr Transfus Hemobiol; 1989 Dec; 32(6):483-4. PubMed ID: 2517013
    [No Abstract]   [Full Text] [Related]  

  • 15. Concerns about ALT testing.
    Kosmin M
    Transfusion; 1982; 22(6):535-7. PubMed ID: 6815842
    [No Abstract]   [Full Text] [Related]  

  • 16. Use of a table-top analyzer for predonation screening for alanine aminotransferase--a cost-effective approach?
    Saxena S; Endahl GL; Shulman IA
    Am J Clin Pathol; 1988 Sep; 90(3):296-9. PubMed ID: 3137804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum alanine aminotransferase of donors in relation to the risk of non-A,non-B hepatitis in recipients: the transfusion-transmitted viruses study.
    Aach RD; Szmuness W; Mosley JW; Hollinger FB; Kahn RA; Stevens CE; Edwards VM; Werch J
    N Engl J Med; 1981 Apr; 304(17):989-94. PubMed ID: 6782484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-transfusion viral hepatitis and the TTVS.
    Holland PV; Bancroft W; Zimmerman H
    N Engl J Med; 1981 Apr; 304(17):1033-5. PubMed ID: 6782483
    [No Abstract]   [Full Text] [Related]  

  • 19. Serum alanine aminotransferase (ALT) assay and incidence of posttransfusion non-A,non-B hepatitis.
    Barcena Marugan R; Zamora C; Moreno A; Erdozain Sosa JC; Perez Hernandez F; Lopez San Roman A
    Transfusion; 1989 Oct; 29(8):751. PubMed ID: 2508279
    [No Abstract]   [Full Text] [Related]  

  • 20. Surrogate testing for non-A, non-B hepatitis in Queensland, Australia: an ALT microtitre tray method for screening blood donors.
    Hyland CA; Douglas R; Mazzocchi R; Young IF
    Pathology; 1988 Jul; 20(3):271-4. PubMed ID: 3144700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.